Literature DB >> 3990587

Elevated natural killer (NK) cell activity: a possible role in resistance to infection and malignancy in immunodeficient splenectomized patients.

A Ferrante, G K Kiroff, D H Goh, P A Drew.   

Abstract

Splenectomized patients, who have had their spleens removed following trauma, have immune deficiencies. However, the risk of infection (with one exception--septicaemia caused mainly by Streptococcus pneumoniae) and malignancy in these patients appears to be comparable to that of healthy individuals. We propose that a compensatory increase in the activity of effector cells, such as natural killer cells (NK) and macrophages, may protect against infection and malignant diseases in splenectomized individuals.

Entities:  

Mesh:

Year:  1985        PMID: 3990587     DOI: 10.1016/0306-9877(85)90067-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Heterotopic autologous splenic grafts in rat. Morphological studies.

Authors:  M T Moore; A S Leong; P A Drew; G K Kiroff; G G Jamieson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Peripheral blood leucocyte subpopulations in patients splenectomized for trauma.

Authors:  A Ferrante; P A Drew; G K Kiroff; H Zola
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

3.  Elevated natural killer (NK) cytotoxicity of mononuclear leucocytes from splenectomized patients: increase in Leu-7+ and Leu-11+ leucocytes.

Authors:  A Ferrante; G K Kiroff; P A Drew
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients.

Authors:  G K Kiroff; A N Hodgen; P A Drew; G G Jamieson
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity.

Authors:  E Kelemen; P Gergely; D Lehoczky; E Triska; J Demeter; P Vargha
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.